Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Sales (2016 - 2025)

Historic Return on Sales for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to 0.1%.

  • Amicus Therapeutics' Return on Sales rose 1500.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.11% for FY2024, which is 2700.0% up from last year.
  • Amicus Therapeutics' Return on Sales amounted to 0.1% in Q3 2025, which was up 1500.0% from 0.16% recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Return on Sales ranged from a high of 0.1% in Q3 2025 and a low of 1.08% during Q1 2022
  • Its 5-year average for Return on Sales is 0.45%, with a median of 0.44% in 2024.
  • Per our database at Business Quant, Amicus Therapeutics' Return on Sales soared by 4800bps in 2021 and then tumbled by -1100bps in 2022.
  • Over the past 5 years, Amicus Therapeutics' Return on Sales (Quarter) stood at 1.01% in 2021, then surged by 37bps to 0.63% in 2022, then surged by 54bps to 0.29% in 2023, then soared by 133bps to 0.1% in 2024, then rose by 4bps to 0.1% in 2025.
  • Its Return on Sales stands at 0.1% for Q3 2025, versus 0.16% for Q2 2025 and 0.17% for Q1 2025.